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Dear Sirs,
The eye of the tiger sign (EOT), seen on T2 sequences of
magnetic resonance imaging (MRI), is considered patho-
gnomonic for neurodegeneration with brain iron accumu-
lation type 1 (NBIA1, previously known as Hallervorden–
Spatz syndrome) [1–3]. This sign is described as low signal
intensity in both globi pallidi (due to iron accumulation)
that surrounds a central region of high signal intensity
(caused by gliosis, edema, and neuronal loss with sub-
sequent secondary vacuolization and cavitation) [1–3]. It
has been occasionally reported in neurodegenerative dis-
orders other than NBIA1, including neuroferritinopathy,
progressive supranuclear palsy, multisystem atrophy, pure
akinesia, and corticobasal degeneration [1–3]. Here, we
describe the first case of EOT-like MRI appearance in a
41-year-old man with Wilson’s disease.
At the age of 24 years, the patient developed dysarthria,
oromandibular dystonia, gait disturbances, and positional
hand tremor. One year later he was diagnosed with Wil-
son’s disease, based on the presence of Kayser–Fleischer
ring and abnormal copper metabolism [i.e. decreased
serum ceruloplasmin (8.2 mg/dL, normal 25–45) and
serum copper (30 lg/dL, normal 70–140 lg/dL) combined
with increased copper urinary excretion (664 lg/24 h,
normal 0–50)]. Genetic examination confirmed compound
heterozygosity, with ATP7B mutations in exon 13 (G988R)
and in exon 7 (IVS7 ? 3A[G). After introduction of
1000 mg/day d-penicillamine, the patient gradually
improved. In 2013 his remaining symptoms were only
slight dysarthria and oromandibular dystonia (occasionally
grimacing). The Kayser–Fleischer rings were no longer
present. However, a routine control brain MRI revealed
abnormalities very similar to EOT sign (Fig. 1).
Fig. 1 The MR image mimicking the ‘‘eye of the tiger’’ sign in T2-
weighted magnetic resonance sequences; bilateral hypointensity in
both putaminal regions and lateral parts of globi pallidi, with a central
hyperintensity (black arrows)
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The difference was that hypointensity tended to localize
in the lateral part of the globus pallidus and putamen instead
of the medial part of the globus pallidus. Subsequent MR
spectroscopy showed that the mean N-acetyloaspartate/
creatine ratio (TE-144mS) in the globus pallidus was 1.55,
and the mean choline/creatine ratio (TE-144 mS) was 1.10
(Fig. 2a). In the normal appearing control region, the values
were 2.37 and 1.08, respectively (Fig. 2b), which may
reflect neuronal loss in the affected area. Noteworthy, the
patient has no co-morbidities, does not drink alcohol and
had no occupational risk factors for tissue metal accumu-
lation. Normal levels of serum iron metabolism markers
(ferritin, iron, total iron binding capacity) combined with
the early age of the disease onset, lack of anemia and
diabetes allowed to exclude aceruloplasminemia and
neuroferritinopathy. The lack of acanthocytosis, pigmen-
tary retinopathy, hypoprobetalipoproteinemia, and good
response to d-penicillamine with no subsequent progression
Fig. 2 The magnetic brain
spectroscopy from: a unaffected
structures in the right temporal
lobe; b central, hyperintensive
part of ‘‘eye of the tiger’’ sign
showing markedly decreased N-
acetyloaspartate in the globus
pallidus as a results of reactive
gliosis
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over 15 years allowed us to exclude NBIA1. The patient’s
brother was diagnosed with hepatic Wilson’s disease
without any neurological signs at 28 years of age.
Wilson’s disease is a treatable, inherited disorder lead-
ing to pathological copper accumulation that damages
affected organs, especially the liver and brain. It has been
suggested that disturbances of iron metabolism occur in the
liver of Wilson’s disease patients, as copper-dependent
enzymes are also involved in its metabolic pathways [4]. In
a recent post-mortem study we demonstrated that iron
accumulates also in the brain [5]. As the EOT sign suggests
accumulation of iron [2, 3, 6, 7], its increased concentration
in the basal ganglia of the reported patient appeared to be
particularly pronounced. However, the exact role of iron-
metabolism disturbances in Wilson’s disease is still
unknown and further studies are needed. Considering that
patients with EOT sign may occasionally have conditions
other than NBIA1, it is advisable to carry out careful dif-
ferential diagnosis in order not to miss a condition that can
be effectively treated.
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